Meng Yuan
-
- Atrial Fibrillation Management and Outcomes 12
- Cardiovascular Function and Risk Factors 8
- Cardiac Fibrosis and Remodeling 6
- Cardiac Arrhythmias and Treatments 5
- Cancer Research top 10%
-
- Effects and risks of endocrine disrupting chemicals 7
-
- Parasitic infections in humans and animals 7
-
- Congenital Anomalies and Fetal Surgery 6
-
- Liver Disease Diagnosis and Treatment 5
In The Last Decade
Meng Yuan
61 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Cardiology and Cardiovascular Medicine 260
- Cancer Research 166
- Health, Toxicology and Mutagenesis 144
- Molecular Biology 503
- Immunology 120
Countries citing papers authored by Meng Yuan
This map shows the geographic impact of Meng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Yuan more than expected).
Fields of papers citing papers by Meng Yuan
This network shows the impact of papers produced by Meng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Yuan. The network helps show where Meng Yuan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 48 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 21 | |
| 14 | 2021 | 14 | |
| 15 | 2020 | 45 | |
| 16 | 2020 | 26 | |
| 17 | 2020 | 28 | |
| 18 | 2020 | 38 | |
| 19 | 2019 | 37 | |
| 20 | 2016 | 12 |
About Meng Yuan
Meng Yuan is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Pathology and Forensic Medicine, having authored 68 papers that have together received 1.2k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (12 papers), Cardiovascular Function and Risk Factors (8 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Parasitic infections in humans and animals (7 papers), Congenital Anomalies and Fetal Surgery (6 papers), Cardiac Fibrosis and Remodeling (6 papers), Cardiac Arrhythmias and Treatments (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (260 citations), Cancer Research (166 citations) and Health, Toxicology and Mutagenesis (144 citations). Meng Yuan has collaborated with scholars based in China, Sweden and Türkiye. Frequent co-authors include Guangping Li, Ren Lin, Lihong Jia, Tong Liu, Fengjuan Wu, Yue Zhang, Qiankun Bao, Gary Tse, Ming Yuan and Xue Liang. Their work appears in journals such as Nature Communications, Scientific Reports and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.